Pharmaceutical Coalition for Patient Access v. United States of America et al.

  1. January 09, 2023

    Justices Jilt Pfizer's Kickback Attack, But Dispute Isn't Done

    The U.S. Supreme Court refused Monday to entertain Pfizer's high-profile challenge to a powerful kickback law that has generated billions of dollars in fraud settlements, but the underlying controversy continues in nearly identical litigation that might soon open a circuit split.

  2. January 05, 2023

    The Hottest FCA Cases & Trends To Watch In 2023

    The never-not-busy False Claims Act realm will be extra active in 2023 as the U.S. Supreme Court delivers at least one FCA opinion — and perhaps two or even three — in headliner cases during a year in which attorneys are also eyeing a new circuit split and emerging enforcement frontiers.

  3. November 09, 2022

    Big Pharma Opens New Front In War On Kickback Restrictions

    A charity bankrolled by drugmaker dollars sued a federal health-fraud watchdog on Wednesday over the specter of kickback enforcement targeting financial help for lucrative medications, echoing a prominent challenge Pfizer has taken to the U.S. Supreme Court.